Controlled multicenter evaluation of a bacteriophage-based method for rapid detection of staphylococcus aureus in positive blood cultures

Journal of Clinical Microbiology

Volumn 51, Issue 4, 2013, Pages 1226-1230

  Bhowmick, T ^a   Mirrett, S ^b,e   Reller, L B ^b   Price, C ^c   Qi, C ^d   Weinstein, M P ^a   Kirna, T J ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOXITIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOPHAGE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GENE AMPLIFICATION; HUMAN; KEYPATH METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS BLOOD CULTURE TEST; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENTIATION; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES; TIME FACTORS; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 84875818435     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02967-12     Document Type: Article

References (36)

1. Pien BC, Sundaram P, Raoof N, Costa SF, Mirrett S, Woods CW, Reller LB, Weinstein MP. 2010. The clinical and prognostic importance of positive blood cultures in adults. Am. J. Med. 123:819-828.
2. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB. 1997. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24:584-602.
3. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG, Jr. 2005. Costs and outcomes among hemodialysisdependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 26: 175-183.
4. Gopal AK, Fowler VG, Jr, Shah M, Gesty-Palmer D, Marr KA, McClelland RS, Kong LK, Gottlieb GS, Lanclos K, Li J, Sexton DJ, Corey GR. 2000. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J. Clin. Oncol. 18:1110-1115.
5. Stryjewski ME, Szczech LA, Benjamin DK, Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG, Jr. 2007. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin. Infect. Dis. 44:190-196.
6. Lee A, Mirrett S, Reller LB, Weinstein MP. 2007. Detection of bloodstream infections in adults: How many blood cultures are needed? J. Clin. Microbiol. 45:3546-3548.
7. Chang FY, Peacock JE, Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL. 2003. Staphylococcus aureus bacteremia: Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine 82:333-339.
8. Kim S-H, Kim K-H, Kim H-B, Kim N-J, Kim E-C, Oh M-D, Choe K-W. 2008. Outcome of vancomycin treatment in patients with methicillinsusceptible Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 52:192-197.
9. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN. 2011. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect. Dis. 11:279.
10. Small PM, Chambers HF. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231.
11. CLSI. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Conterno LO, Wey SB, Castelo A. 1998. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 19: 32-37.
13. Fowler VG, Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ. 2003. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163:2066-2072.
14. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
15. Abramson MA, Sexton DJ. 1999. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs? Infect. Control Hosp. Epidemiol. 20:408-411.
16. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. 2005. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect. Control Hosp. Epidemiol. 26:166-174.
17. Rubio-Terres C, Garau J, Grau S, Martinez-Martinez L, Cast of Resistance Study Group. 2010. Cost of bacteraemia caused by methicillinresistant versus methicillin-susceptible Staphylococcus aureus in Spain: A retrospective cohort study. Clin. Microbiol. Infect. 16:722-728.
18. Shorr AF, Micek ST, Kollef MH. 2008. Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications. Crit. Care Med. 36:2335-2340.
19. Fernandez Guerrero ML, de Gorgolas M. 2006. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis. J. Antimicrob. Chemother. 58:1066-1069.
20. LaPlante KL, Rybak MJ. 2004. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 48:4665-4672.
21. Wood CA, Wisniewski RM. 1994. Lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrob. Agents Chemother. 38:1023-1026.
22. Khatib R, Saeed S, Sharma M, Riederer K, Fakih M, Johnson L. 2006. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 25:181-185.
23. Kim S-H, Park W-B, Lee K-D, Kang C-I, Bang J-W, Kim H-B, Kim E-C, Oh M-D, Choe K-W. 2004. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J. Antimicrob. Chemother. 54:489-497.
24. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. 2003. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin. Infect. Dis. 36:1418-1423.
25. Blanc DS, Basset P, Nahimana-Tessemo I, Jaton K, Greub G, Zanetti G. 2011. High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene J. Clin. Microbiol. 49:722-724.
26. Oliveira K, Brecher SM, Durbin A, Shapiro DS, Schwartz DR, De Girolami PC, Dakos J, Procop GW, Wilson D, Hanna CS, Haase G, Peltroche-Llacsahuanga H, Chapin KC, Musgnug MC, Levi MH, Shoemaker C, Stender H. 2003. Direct identification of Staphylococcus aureus from positive blood culture bottles. J. Clin. Microbiol. 41:889-891.
27. Pape J, Wadlin J, Nachamkin I. 2006. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures. J. Clin. Microbiol. 44:2575-2576.
28. Peterson JF, Riebe KM, Hall GS, Wilson D, Whittier S, Palavecino E, Ledeboer NA. 2010. Spectra MRSA, a new chromogenic agar medium to screen for methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 48:215-219.
29. Brown J, Paladino JA. 2010. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost. Pharmaco. Econ. 28:567-575.
30. Bauer KA, West JE, Balada-Llasat J-M, Pancholi P, Stevenson KB, Goff DA. 2010. An antimicrobial stewardship program's impact. Clin. Infect. Dis. 51:1074-1080.
31. Carver PL, Lin S-W, DePestel DD, Newton DW. 2008. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a university hospital. J. Clin. Microbiol. 46:2381-2383.
32. Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA. 2006. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J. Antimicrob. Chemother. 58:154-158.
33. Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, Oethinger M. 2012. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J. Clin. Microbiol. 50:127-133.
34. Holtzman C, Whitney D, Barlam T, Miller NS. 2011. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J. Clin. Microbiol. 49:1581-1582.
35. Ly T, Pyrgos GJV, Waga M, Shoham S. 2008. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Therapeut. Clin. Risk Manag. 4:637-640.
36. Nguyen DT, Yeh E, Perry S, Luo RF, Pinsky BA, Lee BP, Sisodiya D, Baron EJ, Banaei N. 2010. Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci. J. Clin. Microbiol. 48:785-790.